Position in ALKS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$538,882
+$175,205 QoQ
Shares Held
10,285
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#234
of 421 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JAMES INVESTMENT RESEARCH, INC. holds $4,831,217 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
3,224 | $1,746,859 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
21,004 | $976,896 | |
| 3 | ALKS |
Alkermes plc.
This page
|
10,285 | $538,882 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
61,963 | $519,249 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,027 | $449,376 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
4,650 | $384,927 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
5,940 | $215,028 |
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,882 | 10,285 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $363,677 | 10,285 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $287,354 | 10,270 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $308,100 | 10,270 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $260,579 | 9,108 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $300,746 | 9,108 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $261,946 | 9,108 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $254,932 | 9,108 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||